Active Ingredient(s): Tbo filgrastim
FDA Approved: * August 29, 2012
Pharm Company: * SICOR BIOTECH
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Neutroval Overview

2D9Q, 1CD9, 1GNC, 1PGR, 1RHGIdentifiersAliasesCSF3, C17orf33, CSF3OS, GCSF, colony stimulating factor 3External IDsOMIM: 138970 MGI: 1339751 HomoloGene: 7677 GeneCards: CSF3 Gene location (Human)Chr.Chromosome 17 (human)[1]Band17q21.1Start40,015,361 bp[1]End40,017,813 bp[1]Gene location (Mouse)Chr.Chromosome 11 (mouse)[2]Band11 D|11 62.45 cMStart98,701,263 bp[2]End98,703,629 bp[2]RNA expre...

Read more Neutroval Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Neutroval Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tbo filgrastim
  • Injection: 300mcg/0.5ml, 480mcg/0.8ml, 5mcg/kg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tbo filgrastim or a similar ingredient: (1 result)